Skip to content
  • Monday, 12 October 2026
  • 4:11 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Looking beyond short-term turmoil, Syngene is investing for the future – Pharmaceutical Technology
Pharmaceutical R&D

Looking beyond short-term turmoil, Syngene is investing for the future – Pharmaceutical Technology

Teuku Ryan Sep 17, 2026 0

The global contract research, development, and manufacturing organization (CDMO) sector is undergoing a profound structural evolution, driven by shifting supply…

Read More
Pharmaceutical R&D

HHS Appoints Four Permanent Senior Leaders to Stabilize and Reform the US Food and Drug Administration Amid Leadership Turmoil

Teuku Ryan Sep 11, 2026 0

The US Department of Health and Human Services (HHS) has announced the appointment of four permanent senior leaders to critical…

Read More
Laboratory Automation & Robotics

FDA Commissioner Marty Makary Resigns Amidst Mounting Pressure and Regulatory Turmoil

Lana Keisha Jun 28, 2026 0

Marty Makary resigned on Tuesday as commissioner of the Food and Drug Administration, a departure precipitated by intense administrative pressure…

Read More
Pharmaceutical R&D

FDA Leadership Turmoil Intensifies as Key Officials Ousted Amidst Political Maneuvering

Teuku Ryan May 19, 2026 0

The leadership landscape within the U.S. Department of Health and Human Services (HHS) is undergoing a significant and turbulent transformation,…

Read More
How Medvi Built a $1.8 Billion Telehealth Empire in Regulatory Blind Spots: A Deep Dive into AI, Compounding, and Fragmented OversightThe Paradox of the Dreaming Brain: How Rapid Eye Movement Sleep Rewires Our Metabolic EconomyWHO Issues Landmark Global Guidelines Urging Lifestyle Interventions Over Weight Loss Drugs for Pediatric ObesityOregon State University Researchers Unveil Real-Time Chemical Insights Into Alzheimer’s Protein Clumping and Potential Reversal Strategies
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic Proportions
Teva Pharmaceutical Industries Secures FDA Approval for Weltruza, a Once-Monthly Injectable Olanzapine to Transform Schizophrenia CareTWiV 1288: Clinical update with Dr. Daniel Griffin | Microbe TVScientists discover a hidden factor that can make or break chemical reactionsThe Brain as a Master Regulator: How a Single Protein May Control the Aging Process
YOU MAY HAVE MISSED
Pharmaceutical R&D
Teva Pharmaceutical Industries Secures FDA Approval for Weltruza, a Once-Monthly Injectable Olanzapine to Transform Schizophrenia Care
Teuku Ryan Oct 12, 2026
Microbiology & Immunology
TWiV 1288: Clinical update with Dr. Daniel Griffin | Microbe TV
Lina Irawan Oct 12, 2026
Advanced Materials Science
Scientists discover a hidden factor that can make or break chemical reactions
Nila Kartika Wati Oct 12, 2026
Neuroscience & Brain Research
The Brain as a Master Regulator: How a Single Protein May Control the Aging Process
Rifan Muazin Oct 12, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ